Flex Pharma Reports Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Flex Pharma (FLKS) Tops Q3 EPS by 7c
November 6, 2017 8:05 AM ESTFlex Pharma (NASDAQ: FLKS) reported Q3 EPS of ($0.54), $0.07 better than the analyst estimate of ($0.61). Revenue for the quarter came in at $414 thousand versus the consensus estimate of $480 thousand.
Based on its current operating plans and cash, cash equivalents and marketable securities position,... More
